Aguiar Rosa Sílvia, Moura Branco Luísa, Galrinho Ana, Portugal Guilherme, Abreu Joäo, Cacela Duarte, Fragata José, Cruz Ferreira Rui
Department of Cardiology, Santa Marta Hospital, Lisbon, Portugal.
Department of Cardiothoracic Surgery, Santa Marta Hospital, Lisbon, Portugal.
J Heart Valve Dis. 2016 Mar;25(2):130-138.
Aortic valve replacement (AVR) is the treatment of choice in patients with severe symptomatic aortic stenosis (AS). Patients with a low left ventricular ejection fraction (LVEF) represent a challenge for evaluation and therapeutic decision. Dobutamine stress echocardiography (DSE) allows the distinction to be made between fixed low-flow/low-gradient (LF/LG) AS and pseudosevere AS.
Between 2001 and 2014 a retrospective analysis was conducted of patients who underwent DSE to investigate severe AS. DSE was performed in 3- to 5-min steps up to a maximum dose of 20 μg/kg/min. Parameters evaluated at baseline and at each step of DSE included: left ventricular enddiastolic volume (LVEDV) and left ventricular endsystolic volume (LVESV), maximum gradient (MaxG), mean gradient (MG) and aortic valve area (AVA). AS was considered to be severe if the AVA at peak dose was ≤1 cm2. Patients were allocated to two groups according to their therapy: group 1 received only medical treatment, while group 2 underwent AVR. The average follow up was 51.5 ± 4.4 months.
A total of 41 patients (28 males, 13 females; mean age 71.7 ± 8.3 years) was analyzed. Severe AS was diagnosed in 34 patients (83%). Baseline echocardiographic characteristics were: AVA 0.7 ± 0.2 cm2, MaxG 42.0 ± 9.1 mmHg, MG 25.6 ± 6.4 mmHg, LVEF 33.1 ± 8.4%, LVEDV 149.6 ± 44.5 ml, and LVESV 104.0 ± 42.6 ml. At peak DSE, AVA was 0.8 ± 0.2 cm2, MaxG 62.7 ± 18.2 mmHg, MG 38.1 ± 11.6 mmHg, LVEF 42.2 ± 9.9%, LVEDV 142.6 ± 43.85 ml, and LVESV 89.7 ± 37.4 ml. Nineteen patients were allocated to group 1, and 22 to group 2. In group 2, two patients underwent transcatheter aortic valve implantation (TAVI) and 20 had surgery. Mortality in group 1 was significantly higher than in group 2 (78.9% versus 27.3%). A Cox proportional hazard model analysis showed that no-intervention was the only predictor of mortality (unadjusted to age; hazard ratio (HR) 5.13, 95% confidence interval (CI) 1.96-13.44, p = 0.001; adjusted to age - HR 4.01, 95% CI 1.46-11.01, p = 0.007).
LF/LG AS has a poor prognosis without intervention. DSE allows the lesion severity to be established. In the present study intervention was a predictor of survival during follow up.
主动脉瓣置换术(AVR)是重度症状性主动脉瓣狭窄(AS)患者的首选治疗方法。左心室射血分数(LVEF)较低的患者在评估和治疗决策方面具有挑战性。多巴酚丁胺负荷超声心动图(DSE)可区分固定性低流量/低梯度(LF/LG)AS和假性重度AS。
2001年至2014年,对接受DSE以研究重度AS的患者进行回顾性分析。DSE以3至5分钟的间隔进行,最大剂量为20μg/kg/min。在基线和DSE的每个阶段评估的参数包括:左心室舒张末期容积(LVEDV)、左心室收缩末期容积(LVESV)、最大梯度(MaxG)、平均梯度(MG)和主动脉瓣面积(AVA)。如果峰值剂量时的AVA≤1cm²,则AS被认为是重度的。根据治疗方法将患者分为两组:第1组仅接受药物治疗,而第2组接受AVR。平均随访时间为51.5±4.4个月。
共分析了41例患者(28例男性,13例女性;平均年龄71.7±8.3岁)。34例患者(83%)被诊断为重度AS。基线超声心动图特征为:AVA 0.7±0.2cm²,MaxG 42.0±9.1mmHg,MG 25.6±6.4mmHg,LVEF 33.1±8.4%,LVEDV 149.6±44.5ml,LVESV 104.0±42.6ml。在DSE峰值时,AVA为0.8±0.2cm²,MaxG 62.7±18.2mmHg,MG 38.1±11.6mmHg,LVEF 42.2±9.9%,LVEDV 142.6±43.85ml,LVESV 89.7±37.4ml。19例患者被分配到第1组,22例被分配到第2组。第2组中,2例患者接受经导管主动脉瓣植入术(TAVI),20例接受手术。第1组的死亡率显著高于第2组(78.9%对27.3%)。Cox比例风险模型分析表明,不干预是死亡率的唯一预测因素(未校正年龄;风险比(HR)5.13,95%置信区间(CI)1.96 - 13.44,p = 0.001;校正年龄后 - HR 4.01,95%CI 1.46 - 11.01,p = 0.007)。
未经干预的LF/LG AS预后较差。DSE可确定病变严重程度。在本研究中,干预是随访期间生存的预测因素。